ROSEN, TOP RANKED GLOBAL COUNSEL, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action – NKTR

Monday, March 16, 2026 · the rosen law firm pa

AI Briefing

Investors in Nektar Therapeutics securities may have significant recoveries in a class action lawsuit filed by Rosen Law Firm.
A class action lawsuit has been filed on behalf of purchasers of NKTR securities between February 26, 2025 and December 15, 2025.
Investors must act quickly to serve as lead plaintiff by May 5, 2026.